Beijing Konruns Pharmaceutical Co.,Ltd.
SSE:603590.SS
31.3 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 21.531 | 187.572 | 123.895 | 167.442 | 183.355 | 266.08 | 263.93 | 478.817 | 191.653 | 195.251 | 175.862 | 118.946 |
| Depreciation & Amortization
| 36.459 | 42.94 | 38.716 | 36.144 | 30.036 | 34.66 | 34.56 | 26.787 | 26.521 | 24.97 | 22.248 | 16.217 |
| Deferred Income Tax
| 0 | 0 | -3.154 | 0.826 | -33.058 | -4.426 | -0.123 | 65.601 | 1.339 | -0.51 | 0 | 0 |
| Stock Based Compensation
| 0 | 9.702 | 7.292 | 7.292 | 1.215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -11.475 | -28.596 | -57.845 | -98.796 | -134.917 | -37.939 | -30.246 | 122.726 | -21.733 | 13.282 | -41.401 | 26.123 |
| Accounts Receivables
| 32.672 | -35.738 | -64.937 | -22.561 | 42.053 | -42.593 | -170.593 | -51.387 | -23.404 | -0.317 | 0 | 0 |
| Inventory
| -24.052 | -11.475 | 9.533 | -13.079 | -19.689 | -4.629 | 7.591 | 3.219 | -6.973 | 1.025 | -4.23 | -5.6 |
| Accounts Payables
| 0 | 10.884 | 0.714 | -63.983 | -124.222 | 13.708 | 132.879 | 105.294 | 7.305 | 13.084 | 0 | 0 |
| Other Working Capital
| -20.095 | 7.733 | -3.154 | 0.826 | -33.058 | -4.426 | -37.837 | 119.507 | -14.76 | 12.257 | -37.17 | 31.723 |
| Other Non Cash Items
| 125.73 | -12.264 | 10.787 | -41.995 | 11.774 | -0.796 | -5.135 | -357.843 | -48.181 | -41.698 | -25.732 | 2.434 |
| Operating Cash Flow
| 172.245 | 199.354 | 119.69 | 70.913 | 58.406 | 262.004 | 263.108 | 270.487 | 148.26 | 191.804 | 130.978 | 163.719 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -104.021 | -100.913 | -96.311 | -164.651 | -50.373 | -18.886 | -16.846 | -33.73 | -178.671 | -45.089 | -34.204 | -58.17 |
| Acquisitions Net
| 0 | 0 | 0.001 | -360 | -540 | 18.921 | 16.846 | 33.83 | 0.003 | 0.138 | 0.068 | 0.002 |
| Purchases Of Investments
| -1,395 | -1,693.348 | -630.734 | -687.953 | -1,237.6 | -553.678 | -8.15 | -2.9 | -673.27 | -843.5 | -682.5 | -1,432.25 |
| Sales Maturities Of Investments
| 1,300.59 | 1,328.834 | 387.309 | 584.807 | 1,407.756 | 268.838 | 17.625 | 99.148 | 892.17 | 709.389 | 492.403 | 1,370.427 |
| Other Investing Activites
| 0.03 | 17.712 | 15.229 | -14.651 | -0.618 | -18.886 | -16.846 | -33.73 | -4.567 | 3.83 | 20.35 | 21.47 |
| Investing Cash Flow
| -198.4 | -447.715 | -324.507 | -642.447 | -420.835 | -303.691 | -7.371 | 62.618 | 35.665 | -175.231 | -203.884 | -98.521 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 46.036 | 145.676 | -9.945 | -6.464 | 24.953 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 42.405 | 0 | -0.817 | 62.919 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -0.026 | 0 | -124.642 | -74.517 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -53.492 | -34.949 | -46.947 | -55.183 | -80 | -80 | 0 | 0 | 0 | 0 | 0 | -12.375 |
| Other Financing Activities
| -0.815 | 32.894 | 0 | 119.402 | -26.4 | 0 | 891.349 | -2.519 | -10.232 | -22.747 | 0 | 19.169 |
| Financing Cash Flow
| -8.271 | 143.621 | -56.892 | 57.756 | -93.045 | -80 | 891.349 | -2.519 | -10.232 | -22.747 | 0 | 6.794 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -2.816 | -1.367 | -0.752 | -0.154 | -0 | 0 | 0 | 0 | 0.845 | 0.914 | 0 | 0 |
| Net Change In Cash
| -37.243 | -106.108 | -262.461 | -513.932 | -455.474 | -121.686 | 1,147.086 | 330.586 | 174.539 | -5.259 | -72.905 | 71.992 |
| Cash At End Of Period
| 189.978 | 227.221 | 333.328 | 595.789 | 1,109.722 | 1,565.196 | 1,686.882 | 539.796 | 209.21 | 34.671 | 39.93 | 112.836 |